Correction: Field, M. et al. AbobotulinumtoxinA (Dysport®), OnabotulinumtoxinA (Botox®), and IncobotulinumtoxinA (Xeomin®) Neurotoxin Content and Potential Implications for Duration of Response in Patients
- PMID: 30781899
- PMCID: PMC6410060
- DOI: 10.3390/toxins11020115
Correction: Field, M. et al. AbobotulinumtoxinA (Dysport®), OnabotulinumtoxinA (Botox®), and IncobotulinumtoxinA (Xeomin®) Neurotoxin Content and Potential Implications for Duration of Response in Patients
Abstract
The authors wish to make the following corrections to their paper [...].
Erratum for
-
AbobotulinumtoxinA (Dysport®), OnabotulinumtoxinA (Botox®), and IncobotulinumtoxinA (Xeomin®) Neurotoxin Content and Potential Implications for Duration of Response in Patients.Toxins (Basel). 2018 Dec 13;10(12):535. doi: 10.3390/toxins10120535. Toxins (Basel). 2018. PMID: 30551641 Free PMC article.
References
-
- Field M., Splevins A., Picaut P., Van der Schans M., Langenberg J., Noort D., Foster K. AbobotulinumtoxinA (Dysport®), OnabotulinumtoxinA (Botox®), and IncobotulinumtoxinA (Xeomin®) Neurotoxin Content and Potential Implications for Duration of Response in Patients. Toxins. 2018;10:535. doi: 10.3390/toxins10120535. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
